Karen Fogarty
About Karen Fogarty
Karen Fogarty is the Manager of Quality and Compliance at Bristol Myers Squibb in New York, with over 16 years of experience in various roles within the company.
Current Role at Bristol-Myers Squibb
Karen Fogarty currently serves as the Manager of Quality and Compliance at Bristol-Myers Squibb in New York, New York, United States. In this role, she oversees quality management practices and compliance protocols, contributing to the company's commitment to maintaining high standards in pharmaceutical production and operations.
Previous Roles at Bristol-Myers Squibb
Karen Fogarty has accumulated over 16 years of experience at Bristol-Myers Squibb. She previously held positions including Quality and Compliance Project Lead (2012-2014), Quality Associate (2007-2012), and Senior Drug Safety Associate (2006-2007). These roles have enabled her to develop extensive expertise in quality assurance and compliance within the pharmaceutical industry.
Earlier Career Experience
Before joining Bristol-Myers Squibb, Karen Fogarty worked at various institutions. She was a Drug Safety Specialist at Discovery Labs from 2002 to 2006, a Data Entry Specialist at CDM Associates from 2000 to 2002, and a Registered Nurse at Abington Memorial Hospital from 1998 to 2000. These roles contributed to her comprehensive understanding of drug safety and healthcare.
Educational Background
Karen Fogarty studied at Abington Memorial Hospital Dixon School of Nursing from 1996 to 1998, which provided her with the clinical knowledge and skills that would later inform her work in drug safety and compliance. She also attended Bucks County Community College from 1994 to 1996, furthering her educational qualifications in the healthcare field.
Experience in Drug Safety
Karen Fogarty has significant experience in drug safety, having held roles such as Senior Drug Safety Associate at Bristol-Myers Squibb and Drug Safety Specialist at Discovery Labs. This background has equipped her with the necessary skills to ensure the safety and efficacy of pharmaceutical products, a critical component of her current work in quality and compliance.